MYP_167647
Basic Information
RSV Fgp (488-522)
Antimicrobial
Antiviral
Antiviral Anti-HIV
Antiviral Anti-HIV Anti-HIV-1
Antiviral Anti-Influenza virus
Antiviral Anti-Pneumovirus Anti-RSV
Antiviral Antiviral mechanism Viral entry inhibition
Antiviral Antiviral mechanism Viral fusion inhibition
Antiviral Antiviral mechanism Viral fusion inhibition Fusion inhibitor
Therapeutic / Biomedical activity Protective bioactivity Cell protection Cytoprotection
Standard
35 amino acids
C168H273N49O56
Standard
Sequence
FDASISQVNEKINQSLAFIRKSDELLHNVNAGKST
Physicochemical Analysis
3875.26 Da
6.76
-0.15
-0.41
-0.0042
-0.43
0.65
-0.07
28.90
92.00
0.0571
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1750.48
-21.68
59.0
57.0
135.0
273.0
3.0
40.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0414052 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
Amidation
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 LAI | HEp-2 cells
12.9 μM
EC50
Mammalian: 1.1 h; Yeast: 3 min; E. coli: 2 min
Showing 1 records on this page · Page 3 of 3